REFERENCES
Kelley, B. 2020. Developing therapeutic monoclonal antibodies at
pandemic pace. Nat Biotechnol 38:540-545.
Puck, T.T., S.J. Cieciura, and A. Robinson. 1958. Genetics of somatic
mammalian cells. III. Long-term cultivation of euploid cells from human
and animal subjects. J Exp Med 108:945-956.
Rajendra, Y., S. Balasubramanian, R.B. Peery, J.R. Swartling, N.A.
McCracken, D.L. Norris, C.C. Frye, and G.C. Barnard. 2017. Bioreactor
scale up and protein product quality characterization of piggyBac
transposon derived CHO pools. Biotechnol Prog 33:534-540.
Rajendran, S., S. Balasubramanian, L. Webster, M. Lee, D. Vavilala, N.
Kulikov, J. Choi, C. Tang, M. Hunter, R. Wang, H. Kaur, S. Karunakaran,
V. Sitaraman, J. Minshull, and F. Boldog. 2021. Accelerating and
de-risking CMC development with transposon-derived manufacturing cell
lines. Biotechnol Bioeng
Wilson, M.H., C.J. Coates, and A.L. George, Jr. 2007. PiggyBac
transposon-mediated gene transfer in human cells. Mol Ther15:139-145.